|
|
|
|
|
|
|
|
|
|
|
|
|
30.09.25 - 12:06
|
Rockwell Medical Promotes Heather Hunter to Chief Operating Officer (Business Wire)
|
|
|
WIXOM, Mich.--(BUSINESS WIRE)--$RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Heather Hunter was promoted to Chief Operating Officer, and will continue to report to the Company's President and CEO, Dr. Mark Strobeck.
Ms. Hunter joined Rockwell Medical as SVP, Chief Corporate Affairs Officer in August 2022 to revitalize the Company's investor relations, corporate communications, brand reputation, and market credibility. Subsequently, Ms. Hunter assumed responsibility for other functional areas including information technology and transportation. In her new role as Chief Operating Officer, Ms. Hunter will focus on modernizing infrastructure, processes, and systems, implementing operational efficiencies, and aligning execution with Rockwell Medical's strategic priorities to enhance shareh...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.08.25 - 12:03
|
Rockwell Medical Announces Second Quarter 2025 Results (Business Wire)
|
|
|
Generated $1.8 million in cash flow from operations for the second quarter of 2025.
Reported gross margin of 16% for the second quarter of 2025, in line with 2025 guidance.
Increased cash position at June 30, 2025 to $18.4 million.
WIXOM, Mich.--(BUSINESS WIRE)--$RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and six months ended June 30, 2025.
"During the second quarter of 2025, we successfully managed through the transition of our largest customer away from Rockwell Medical and now find ourselves at a steady state, which we believe positions us well for continued growth," said Mark Strobeck, Ph.D., Rockwell Medical's President and CEO. "Our long-standing reputation for high-quality products, a reliable supply chain, and excellent...
|
|
|
|
|
17.07.25 - 12:06
|
Rockwell Medical to Release Second Quarter 2025 Results on Thursday, August 14, 2025 (Business Wire)
|
|
|
WIXOM, Mich.--(BUSINESS WIRE)--$RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.
CONFERENCE CALL AND WEBCAST DETAILS
Date: Thursday, August 14, 2025
Time: 8:00am ET
Live Number: (888) 660-6347 // (International) 1 (929) 201-6594
Conference Call ID: 4944610
Webcast and Replay: www.RockwellMed.com/Results
Speakers:
Mark Strobeck, Ph.D. — President and Chief Executive Officer; and
Jesse Neri — SVP, Chief Financial Officer
Tim Chole — SVP, Chief Commercial Officer
Format: Discussion of second quarter 2025 financial and operational results followed by Q&A...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
